Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

5X22

Crystal structure of Thermus thermophilus transcription initiation complex with GpA and CMPcPP

Summary for 5X22
Entry DOI10.2210/pdb5x22/pdb
Related5X21
DescriptorDNA-directed RNA polymerase subunit alpha, ZINC ION, 5'-O-[(S)-hydroxy{[(S)-hydroxy(phosphonooxy)phosphoryl]methyl}phosphoryl]cytidine, ... (11 entities in total)
Functional Keywordstranscription, rna polymerase, primer-dependent initiation, transferase-dna complex, transferase/dna
Biological sourceThermus thermophilus
More
Total number of polymer chains18
Total formula weight890215.67
Authors
Zhang, Y.,Ebright, R. (deposition date: 2017-01-29, release date: 2017-07-05, Last modification date: 2024-11-20)
Primary citationMaffioli, S.I.,Zhang, Y.,Degen, D.,Carzaniga, T.,Del Gatto, G.,Serina, S.,Monciardini, P.,Mazzetti, C.,Guglierame, P.,Candiani, G.,Chiriac, A.I.,Facchetti, G.,Kaltofen, P.,Sahl, H.G.,Deho, G.,Donadio, S.,Ebright, R.H.
Antibacterial Nucleoside-Analog Inhibitor of Bacterial RNA Polymerase.
Cell, 169:1240-1248.e23, 2017
Cited by
PubMed Abstract: Drug-resistant bacterial pathogens pose an urgent public-health crisis. Here, we report the discovery, from microbial-extract screening, of a nucleoside-analog inhibitor that inhibits bacterial RNA polymerase (RNAP) and exhibits antibacterial activity against drug-resistant bacterial pathogens: pseudouridimycin (PUM). PUM is a natural product comprising a formamidinylated, N-hydroxylated Gly-Gln dipeptide conjugated to 6'-amino-pseudouridine. PUM potently and selectively inhibits bacterial RNAP in vitro, inhibits bacterial growth in culture, and clears infection in a mouse model of Streptococcus pyogenes peritonitis. PUM inhibits RNAP through a binding site on RNAP (the NTP addition site) and mechanism (competition with UTP for occupancy of the NTP addition site) that differ from those of the RNAP inhibitor and current antibacterial drug rifampin (Rif). PUM exhibits additive antibacterial activity when co-administered with Rif, exhibits no cross-resistance with Rif, and exhibits a spontaneous resistance rate an order-of-magnitude lower than that of Rif. PUM is a highly promising lead for antibacterial therapy.
PubMed: 28622509
DOI: 10.1016/j.cell.2017.05.042
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (3.35 Å)
Structure validation

227561

PDB entries from 2024-11-20

PDB statisticsPDBj update infoContact PDBjnumon